CIPROFLOXACIN in pharma franchise in Mizoram

CIPROFLOXACIN MG PCD pharma franchise in Shimla

CIPROFLOXACIN in top pharma company in Delhi

CIPROFLOXACIN in pcd pharma supplier in Nagpur

CIPROFLOXACIN in phama franchise company in india
CIPROFLOXACIN in phama distributor in Vadodara

Home/Products /ciprofloxacin-0-point-3-dexamethasone-0-point-1-drop

About the Product

Description


Ciproplit D Eye/Ear Drops is a combination of a powerful antibiotic and a corticosteroid, designed to treat eye and ear infections associated with inflammation. It is formulated with Ciprofloxacin, a fluoroquinolone antibiotic, and Dexamethasone, a potent corticosteroid, to deliver dual-action therapy—eliminating bacterial pathogens while controlling inflammatory symptoms like redness, swelling, and itching.

Ciprofloxacin works by inhibiting bacterial DNA gyrase, preventing the bacteria from replicating and repairing its DNA, which ultimately leads to bacterial cell death. It is effective against a broad range of gram-positive and gram-negative bacteria commonly responsible for ocular and aural infections such as bacterial conjunctivitis, keratitis, corneal ulcers, blepharitis, otitis externa, and other related conditions.

Dexamethasone provides powerful anti-inflammatory action. It helps alleviate pain, swelling, and irritation by suppressing the immune response to infection or injury. This is particularly beneficial in reducing tissue damage caused by prolonged inflammation and improving patient comfort and healing outcomes.

Together, Ciprofloxacin and Dexamethasone offer synergistic benefits in managing post-surgical complications, trauma-related infections, and inflammatory conditions of the eye and ear. The formulation is ideal for short-term therapy under medical supervision and is widely used in ophthalmic and otologic practices.

The solution is sterile, easy to apply, and delivered in a convenient dropper bottle to ensure precise administration. It is suitable for adults and children when prescribed by a healthcare provider. Ciproplit D is trusted by clinicians for its efficacy, safety profile, and ability to address both infection and inflammation in a single formulation.


May cause temporary burning, stinging, or blurred vision. Rarely, allergic reactions or increased intraocular pressure may occur with prolonged use.

Indicated for bacterial eye and ear infections with associated inflammation, including conjunctivitis, blepharitis, keratitis, and otitis externa.

For external use only. Avoid touching the dropper to any surface. Use under strict medical supervision and avoid prolonged use without consulting a healthcare provider.

Store below 25°C. Protect from light. Do not freeze. Keep the bottle tightly closed after each use.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ciprofloxacin 0.3% + Dexamethasone 0.1% Drop in the PCD pharma franchise market?

Ciprofloxacin 0.3% + Dexamethasone 0.1% Drop has strong demand in the ophthalmic and ENT segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.

Why should medical distributors include Ciprofloxacin 0.3% + Dexamethasone 0.1% Drop in their product range?

Medical distributors and wholesalers can benefit from the consistent demand for this combination in bacterial infections with inflammation in eyes and ears. Including this product helps strengthen their ophthalmic and ENT antibiotic-steroid portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Ciprofloxacin 0.3% + Dexamethasone 0.1% Drop?

Yes, Cafoli Lifecare offers PCD pharma franchise opportunities for Ciprofloxacin 0.3% + Dexamethasone 0.1% Drop with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for Ciprofloxacin 0.3% + Dexamethasone 0.1% Drop distribution?

Wholesalers and medical agencies benefit from attractive business margins, steady demand in ophthalmic and ENT infections with inflammation control, timely product availability, and professional marketing support when partnering with Cafoli Lifecare for this formulation.

How can I become a distributor or franchise partner for Ciprofloxacin 0.3% + Dexamethasone 0.1% Drop?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this eye/ear drop can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.